Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with prostate cancer who have had their prostate surgically removed and whose PSA levels are rising again, with imaging scans (PET and MRI) showing the cancer has come back only in the area where the prostate used to be.
- The area where the cancer has returned must be visible on a specific type of ultrasound scan (called TRUS), so that the treatment device can be placed accurately.
- A biopsy (tissue sample) to confirm the cancer is recommended but not required.
- People who have read and signed a consent form explaining that this is an investigational treatment and what other standard treatment options exist.
Who may not be able to join:
- People whose cancer has spread to other parts of the body beyond the prostate bed area.
- People whose cancer has only returned in the lymph nodes.
- People who have previously had radiation treatment to the prostate bed area.
- People whose cancer has returned in more than one separate location in the prostate bed area.
- People with a life expectancy of less than 5 years, or those who are unable to tolerate or complete the treatment procedure involved in this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rafael Martínez-Monge, M.D., Clinica Universidad de Navarra Cancer Center
Phone: 948255400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
biochemical relapse-free survival (bRFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.